COMMUNIQUÉS West-GlobeNewswire

Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference
05/03/2018
REDWOOD CITY, Calif, March 05, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will be [...]
Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
PhaseBio Announces Appointments to Board of Directors
05/03/2018
MALVERN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced the appointment of [...]
Synergy CHC Corp. to Present at 30th Annual Roth Conference on March 13th
05/03/2018
Westbrook, Maine, March 05, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ), a leading omni-channel consumer health and beauty company, announced today that Jeffrey Kadanoff, Chief Financial Officer, is [...]
Immunomedics to Present at Cowen and Company 38th Annual Health Care Conference
05/03/2018
MORRIS PLANS, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will present an [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
05/03/2018
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that company management will participate in the following investor conferences: Cowen and Company 38 th [...]
Emerald Health Therapeutics and Village Farms International Announce Cannabis Cultivation License for 1.1 Million Ft2 Delta 3 Greenhouse Operation
05/03/2018
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSX-V: EHT ) (OTCQX:EMHTF) and Village Farms International, Inc. (Village Farms) (TSX: VFF ) (OTCQX:VFFIF) [...]
Avenue Therapeutics to Present at March Investor Conferences
05/03/2018
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Lucy Lu, M [...]
Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
05/03/2018
Company expects to discontinue the program Conference call and webcast today at 8:30 a.m. ET / 5:30 a.m. PT MENLO PARK, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical [...]
Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018
05/03/2018
FRAMINGHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit
05/03/2018
CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”) (NASDAQ: AEZS ) and (TSX: AEZS ) announced today that the United States District Court for the District of [...]
Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting
05/03/2018
~ Post-Hoc Analysis of Phase 3 Placebo-Controlled Study of KEVEYIS Showed Adolescents had Similar Improvements in Short-Term Attack Rates as Adults ~ ~ Pooled Analysis of Two Phase 3 Studies Further Demonstrate the [...]
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2018
05/03/2018
CRANBURY, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced upcoming presentations at two investor conferences in March. John F. Crowley, Chairman and Chief Executive Officer, [...]
FDA Approves PDUFA Fee Waiver for Gimoti™ New Drug Application
05/03/2018
SOLANA BEACH, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. [...]
Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance
05/03/2018
Record Quarterly Revenues of $23.4 Million Represent a 41% Increase Over Fourth Quarter 2016 Positive Operating and Net Income Reported for the Fourth Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass [...]
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- At three upcoming investor conferences in March, Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ) President, Chief Executive Officer and co-founder, Steven J. Mento, Ph.D., and [...]
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
05/03/2018
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that the Company’s previously announced rights offering (“the Rights [...]
Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston
05/03/2018
Press release - No. 06 / 2018 Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston Copenhagen, March 5, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO [...]
Biohit Oyj - Managers' Transactions
05/03/2018
Biohit Oyj - Managers' Transactions, March 5, 2018 at 2:10 pm local time (EEST) Biohit Oyj has received the following notification. Biohit Oyj - Managers' Transactions ____________________________________________ Person [...]

Pages